当前位置: 首页 > 期刊 > 《世界中医药》 > 2021年第14期
编号:215797
单核细胞/高密度脂蛋白胆固醇比值与冠心病血瘀证相关性研究
http://www.100md.com 2021年9月13日 世界中医药 2021年第14期
     彭菊琴 任钧国 张艺楠 李春岩

    摘要 目的:探讨单核细胞/高密度脂蛋白胆固醇比值(MHR)与冠心病血瘀证的相关性。方法:选取2018年1月至2018年7月中日友好医院收治的冠心病患者180例作为研究对象,根据冠心病血瘀证积分分为血瘀证组(n=118)和非血瘀证组(n=62),选取同期非冠心病非血瘀证患者55例作为对照组,比较3组MHR的差异。采用Logistic回归分析MHR与冠心病血瘀证的关系;通过绘制受试者工作特征曲线(ROC),评估MHR诊断冠心病血瘀证的能力。结果:血瘀证组MHR水平高于非血瘀证组和对照组(P0.05)。Logistic回归分析表明,MHR是冠心病血瘀证的独立危险因素(HR:0.903,95%CI为0.826~0.988,P=0.026)。ROC分析表明,MHR诊断冠心病血瘀证的最佳截止值为14.15,敏感度为83.9%,特异度为68.6%[曲线下面积(AUC)0.609,95%CI为0.521~0.696,P=0.017]。结论:MHR是冠心病血瘀证的独立危险因素,提示脂质驱动的炎症反应可能是冠心病血瘀证形成病理机制之一。

    关键词 冠心病;血瘀证;单核细胞/高密度脂蛋白胆固醇比值;炎症;脂质代谢紊乱;理化指标;诊断;相关性

    Abstract Objective:To analyze the relationship between monocyte to high-density lipoprotein cholesterol ratio(MHR)with blood-stasis syndrome(BSS)in coronary heart disease(CHD).Methods:A total of 180 CHD inpatients admitted to China-Japan Friendship Hospital from January 2018 to July 2018 were selected as the research objects and were divided into a BSS group(118 cases)and a non-BSS group(62 cases)according to the score of BSS in CHD.A total of 55 participants with non-CHD and non-BSS were recruited as control group.The levels of MHR was compared among 3 groups.Logistic regression was used to analyze the relationship between MHR and BSS score.And receiver operating characteristic(ROC)curve was drawn to evaluate the ability of MHR to diagnose BSS of coronary CHD.Results:The levels of MHR in the BSS group was significantly higher than non-BSS group and control group(P0.05).Logistic regression analysis showed that MHR was an independent risk factor for BSS in CHD [HR:0.903 ......

您现在查看是摘要页,全文长 16530 字符